Samitivej International Children's Hospital Expands, Advancing Pediatric Healthcare in Asia-Pacific
A 2 Billion THB Investment in Pediatric Excellence and Smart Hospital Innovation
BANGKOK, THAILAND - Media OutReach Newswire - 27 February 2025 - Samitivej Hospital, a leader in pediatric care, unveils its newly expanded standalone Samitivej International Children's Hospital at Samitivej Srinakarin Hospital. Backed by a 2 billion THB investment, the expansion strengthens Samitivej's commitment to becoming Asia-Pacific's Leading Pediatric Referral Hub, providing specialized care, innovative treatments, and seamless medical coordination.
The upgraded facility serves patients from Thailand and beyond, earning a strong reputation in Vietnam, Laos, Cambodia, Indonesia, Brunei, Saudi Arabia, the UAE, Kuwait, Oman, and Qatar, reinforcing its global healthcare role.
Revolutionizing Pediatric Care with Advanced Treatments
Samitivej International Children's Hospital redefines pediatric excellence, offering cutting-edge treatments for complex and rare conditions:
Open-Heart Surgery to Minimally Invasive Catheterization – Complete heart care from birth, ensuring advanced treatment and faster recovery.
Haploidentical Bone Marrow Transplant (BMT) to CAR-T Cell Therapy – Advanced treatments for blood disorders and cancer.
Comprehensive Pediatric and Newborn Surgery – Expertise in performing procedures from head to toe, led by specialized doctors.
Epilepsy Treatment with Medication to Vagus Nerve Stimulation (VNS) Implants – Solutions for drug-resistant epilepsy.
Advancing Pediatric Excellence with Cutting-Edge Facilities
The new eight-floor hospital features 111 beds, including 12 for critically ill children and 8 neonatal intensive care beds. It integrates Smart Hospital technology for efficiency and patient-centered care. Key features include:
Hybrid Operating Room: Precision-driven newborn and pediatric surgical procedures using biplane imaging technology.
World-Class Pediatric Specialties: Multidisciplinary teams treating complex and rare conditions.
Advanced Neonatal & Pediatric Intensive Care: Specialized care for premature infants under 500 grams.
Cutting-Edge Rehabilitation Center: Robotic-assisted gait training, Hybrid Assistive Limb (HAL) therapy, and Redcord NEURAC systems.
Comprehensive International Patient Services: Pre-arrival teleconsultations, aeromedical transport, multilingual care teams, follow-up appointments, and medical evacuation and repatriation.
Global Partnerships & Medical Expertise
Samitivej collaborates with Doernbecher Children's Hospital (OHSU, USA) to enhance care for critically ill children, newborns, and trauma patients. A partnership with Takatsuki General Hospital (Japan) ensures specialized neonatal and allergy treatments, providing access to the latest pediatric advancements.
Pioneering Smart Hospital Innovations
Samitivej leads in digital healthcare, integrating technology to enhance efficiency and care:
Well Kidz App: Manages medical records, appointments, and remote consultations.
Smart ER & Smart Ambulance Services: Real-time monitoring ensures rapid emergency response.
Smart OPD & Smart IPD: AI-powered cost estimation, queue tracking, and seamless patient-medical team communication.
D-Discharge System: Streamlined hospital discharge for greater convenience.
Exceptional Pediatric Outcomes & Achievements
Samitivej delivers outstanding results:
7,000+ critical pediatric cases treated annually
1,000+ newborn and pediatric surgeries performed, including minimally invasive procedures
92% one-year survival rate for bone marrow transplants, surpassing global benchmarks
400+ newborns with heart conditions successfully treated through surgical correction
Specialized care provided for premature infants with birth weights below 500 grams
98% trust rating from families
A Commitment to a Healthier Future for Every Child
Dr. Surangkana Techapaitoon, Deputy CEO of Samitivej and BNH Hospitals and Director of Samitivej International Children's Hospital, stated:
' We want to see a healthier future for every child by integrating innovation, world-class expertise, and compassionate care. This facility strengthens our role as a leading pediatric referral hub, expanding access to specialized treatment and ensuring children everywhere receive the best care from infancy through adolescence.'
Hashtag: #SamitivejInternationalChildrensHospital
The issuer is solely responsible for the content of this announcement.
About Samitivej Hospital
Samitivej is a JCI-accredited hospital group, offering world-class care since 1979. With seven hospitals, it is a leading provider of healthcare in Thailand and Southeast Asia, serving both locals and expatriates.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
an hour ago
- CBS News
Major delay on BART Richmond line because of "major medical emergency" at North Berkeley station
What was described as a "major medical emergency" at the North Berkeley BART station led to major delays on the Richmond line Monday morning, the agency said. Just after 10 a.m., BART said the North Berkeley station was closed because of the incident, which halted Red Line service and led to delays on the line in all directions. A BART spokesperson said preliminary information was that a person entered the trackway, and a collision may have occurred with a train. Later, spokesperson Chris Filippi said that a person was removed from the trackway and was taken to a hospital. The station was reopened just before 11 a.m. and Red Line service resumed, but residual delays remained.
Yahoo
a day ago
- Yahoo
Colombian senator Uribe had procedures on head, thigh, is in ICU-hospial
BOGOTA (Reuters) -The Santa Fe Foundation hospital where Colombian Senator Miguel Uribe was treated after he was shot on Saturday, said in a Sunday statement he had procedures on his head and his left thigh but remained in intensive care as doctors seek to stabilize his condition.
Yahoo
a day ago
- Yahoo
Common cholesterol-busting pill cuts death risk of critical illness 39pc
People who are critically ill with sepsis may be more likely to survive if they are given statins, a new study suggests. Researchers wanted to explore whether the cholesterol-busting drugs may bring additional benefits for patients. The new study examined information on sepsis patients who received statins during a stint in intensive care and compared it with patients in a similar situation who did not receive statins. Some 14.3% of 6,000 sepsis patients who were given statins died within 28 days. This is compared with 23.4% of 6,000 patients who did not receive statin therapy. The research team from China said that this equates to a 39% reduced risk of death within a month. READ MORE: Android users urged to update their phones 'immediately' for this reason READ MORE: Watchdog's warning over prices at Sports Direct The research, based on data from thousands of patients at a hospital in Israel between 2008 and 2019, also found that 7.4% of statin patients died while in the intensive care unit compared with 13.6% of those who did not receive statins. And during their overall hospital stay, some 11.5% of sepsis patients who were given statins died, compared with 19.1% of sepsis patients who did not take statins. However, it appeared that those who were not prescribed statins had a slightly shorter hospital stay compared with those who did receive them – an average of eight days compared with almost 10 days. 'We found that statin users exhibited decreased 28-day all-cause mortality,' the authors wrote in the journal Frontiers in Immunology. Sepsis is a life-threatening reaction to an infection that occurs when the immune system overreacts and starts to damage the body's tissues and organs. In the UK, 245,000 people are affected by sepsis every year. UK sepsis experts said that 'anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored' as they called for larger trials to confirm the findings. Statins are known as cholesterol-busting drugs because they can help lower the level of low-density lipoprotein (LDL) cholesterol in the blood. But experts said that they also have other benefits, including reducing inflammation and antibacterial effects. The research team called for larger trials to confirm their findings. 'Our large, matched cohort study found that treatment with statins was associated with a 39% lower death rate for critically ill patients with sepsis, when measured over 28 days after hospital admission,' said Dr Caifeng Li, the study's corresponding author and an associate professor at Tianjin Medical University General Hospital in China. 'These results strongly suggest that statins may provide a protective effect and improve clinical outcomes for patients with sepsis.' Commenting on the study, Dr Ron Daniels, founder and chief executive of the UK Sepsis Trust, said: 'It has been known for some time that the anti-inflammatory properties of statins confer a survival benefit on those who take them if they develop sepsis. Whilst previous studies have failed to show a similar survival benefit in treating people with sepsis with statins, this new study supports calls for a large, multi-country, randomised control trial. 'Anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored.'
